NASDAQ:MGRX

Mangoceuticals Q3 2026 Earnings Results & Report

Mangoceuticals logo
$0.12 -0.01 (-7.55%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$0.13 +0.01 (+4.37%)
As of 11/20/2026 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Mangoceuticals reported Q3 2026 earnings on November 16, 2026. The company reported EPS of -$0.19, while revenue was $69.50 thousand.

Earnings Announcement Details

Quarter
Q3 2026
Time
Before Market Opens
Conference Call
7:00 AM ET

Mangoceuticals EPS Results

Actual EPS
-$0.19
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Mangoceuticals Revenue Results

Actual Revenue
$69.50 thousand
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Earnings Documents

Mangoceuticals Q3 2026 Earnings FAQ

Mangoceuticals (NASDAQ:MGRX) reported earnings of -$0.19 per share for Q3 2026. The report was announced on Monday, November 16, 2026.

Mangoceuticals reported revenue of $69.50 thousand for Q3 2026.

Mangoceuticals Earnings Headlines

What the hell is going on?
Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.tc pixel
See More Mangoceuticals Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Mangoceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Mangoceuticals and other key companies, straight to your email.

About Mangoceuticals

Mangoceuticals (NASDAQ:MGRX) is a men’s health and wellness company that offers telehealth services through its online platform. The platform connects customers with healthcare providers for consultations and, when appropriate, prescription treatments.

The company’s offerings have included treatments for erectile dysfunction, hair loss and testosterone-related concerns, as well as weight-management services. Prescriptions are fulfilled through pharmacy partners.

Mangoceuticals primarily serves customers in the United States through its digital platform.

View Mangoceuticals Profile